Literature DB >> 9538989

Management of dyslipidemia in adults with diabetes. American Diabetes Association.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538989     DOI: 10.2337/diacare.21.1.179

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  11 in total

1.  Global risk assessment for lipid therapy to prevent coronary heart disease.

Authors:  C M Nass; S D Wiviott; J K Allen; W S Post; a R Blumenthal
Journal:  Curr Cardiol Rep       Date:  2000-09       Impact factor: 2.931

Review 2.  Diabetic dyslipidaemia: current treatment recommendations.

Authors:  J D Best; D N O'Neal
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

3.  Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial.

Authors:  Sheldon W Tobe; George Pylypchuk; Joan Wentworth; Alexander Kiss; John Paul Szalai; Nancy Perkins; Susan Hartman; Laurie Ironstand; Jacqueline Hoppe
Journal:  CMAJ       Date:  2006-04-04       Impact factor: 8.262

4.  Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patients with diabetes mellitus: a population-based cohort study.

Authors:  Xia Sheng; Michael J Murphy; Thomas M MacDonald; Li Wei
Journal:  Eur J Clin Pharmacol       Date:  2012-02-22       Impact factor: 2.953

5.  Elevated serum squalene and cholesterol synthesis markers in pregnant obese women with gestational diabetes mellitus.

Authors:  Helena E Miettinen; Kristiina Rönö; Saila Koivusalo; Beata Stach-Lempinen; Maritta Pöyhönen-Alho; Johan G Eriksson; Timo P Hiltunen; Helena Gylling
Journal:  J Lipid Res       Date:  2014-10-09       Impact factor: 5.922

6.  The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population.

Authors:  Xia Sheng; Michael J Murphy; Thomas M MacDonald; Li Wei
Journal:  BMC Public Health       Date:  2012-08-30       Impact factor: 3.295

7.  Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.

Authors:  Adie Viljoen; Anthony S Wierzbicki
Journal:  Drug Healthc Patient Saf       Date:  2010-05-24

Review 8.  Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.

Authors:  J Hartweg; R Perera; V Montori; S Dinneen; H A W Neil; A Farmer
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

9.  Lotus leaf alleviates hyperglycemia and dyslipidemia in animal model of diabetes mellitus.

Authors:  Ah-Rong Kim; Soo-Mi Jeong; Min-Jung Kang; Yang-Hee Jang; Ha-Neul Choi; Jung-In Kim
Journal:  Nutr Res Pract       Date:  2013-06-03       Impact factor: 1.926

10.  Coronary Atherosclerotic Plaque Detected by Computed Tomographic Angiography in Subjects with Diabetes Compared to Those without Diabetes.

Authors:  Bahram Khazai; Yanting Luo; Steven Rosenberg; James Wingrove; Matthew J Budoff
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.